- Home
- FOLD vs OPCH Comparison
FOLD vs OPCH Comparison
Compare FOLD & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOLD | OPCH |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.0B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | FOLD | OPCH |
|---|---|---|
| Price | $14.30 | $34.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | $26.11 | ★ $37.44 |
| AVG Volume (30 Days) | ★ 7.8M | 1.9M |
| Earning Date | 02-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.77 |
| EPS | N/A | ★ 1.27 |
| Revenue | $598,704,000.00 | ★ $5,530,491,000.00 |
| Revenue This Year | $21.49 | $15.20 |
| Revenue Next Year | $18.46 | $6.23 |
| P/E Ratio | ★ N/A | $26.91 |
| Revenue Growth | ★ 21.28 | 15.79 |
| 52 Week Low | $5.51 | $24.24 |
| 52 Week High | $14.38 | $36.80 |
Technical Indicators
Market Signals| Indicator | FOLD | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 79.26 | 52.02 |
| Support Level | $14.30 | $33.60 |
| Resistance Level | $14.31 | $34.97 |
| Average True Range (ATR) | 0.03 | 0.99 |
| MACD | -0.13 | -0.28 |
| Stochastic Oscillator | 35.00 | 23.04 |
Price Performance
Historical ComparisonAbout FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.